Blinatumomab: no ka leukemia lymphoblastic huʻi
Anter
ʻO Blinatumomab kahi lāʻau lapaʻau hiki ke hoʻokomo ʻia e hana ma ke ʻano he antibody, e paʻa ana i nā membrane o nā hunaola maʻi ʻaʻai a ʻae iā lākou e ʻike maʻalahi ʻia e ka ʻōnaehana pale. No laila, ʻoi aku ka maʻalahi o ka manawa o nā hunaola pale e hoʻopau i nā hunaola maʻi ʻaʻai, keu hoʻi i ka hihia o ka leukemia lymphoblastic nui.
Hiki ke ʻike ʻia kēia lāʻau lapaʻau ma ke ʻano kālepa ʻo Blincyto a pono e hoʻohana wale ʻia i ka haukapila no ka mālama ʻana i ka maʻi ʻaʻai, ma lalo o ke alakaʻi a kahi oncologist.
Kumukūʻai
ʻAʻole hiki ke kūʻai ʻia kēia lāʻau i loko o nā hale kūʻai lāʻau lapaʻau maʻamau, hoʻohana wale ʻia i ka wā o ka mālama ʻana i ka maʻi ʻaʻai i ka haukapila a i ʻole nā kikowaena kūikawā, e like me INCA, no ka laʻana.
No ke aha ia
Hōʻike ʻia ʻo Blinatumomab no ka mālama ʻana i ka leukemia lymphoblastic ly prechooror B-cell, Philadelphia chromosome maikaʻi ʻole, i ka hoʻi hou ʻana a i ʻole ka refractory.
Pehea e ho ohana
ʻO ke ana o ka blinatumomab e lawelawe ʻia e alakaʻi mau ʻia e kahi oncologist, no ka mea he loli ia e like me ke ʻano o ke kanaka a me ke kahua o ka ulu ʻana o ka maʻi.
Hana ʻia ka lapaʻau me 2 pōʻaiapuni o 4 mau pule pākahi, hoʻokaʻawale ʻia e 2 mau pule, a pono ʻoe e haukapila ʻia i nā lā 9 mua o ka pōʻaiapuni mua a no 2 mau lā o ka pōʻaiapili ʻelua.
Nā hopena ʻē aʻe
ʻO nā hopena maʻa mau o ka hoʻohana ʻana i kēia lapaʻau me ka anemia, ka luhi nui loa, ke koko kiʻekiʻe, ka hiamoe, ka ʻeha, ka haʻalulu, ka lōlō, ka uha, ka pīhoihoi, ka luaʻi, ka paʻa ʻana o ka ʻeha, ka ʻeha o ka ʻōpū, ka ʻehaʻeha, ka ʻeha ma nā hono, ka haʻalulu a nā hoʻololi i ka hoʻāʻo ʻana i ke koko.
ʻO wai ka mea pono ʻole e hoʻohana
Hoʻohālikelike ʻia ʻo Blinatumomab no nā wahine e hānai ana i nā waiū a me nā poʻe me nā maʻi āpau i kekahi o nā ʻāpana o ka haʻilula. Eia hou, i ka hihia o nā wahine hāpai, pono e hoʻohana wale ʻia ia ma lalo o ke alakaʻi a ka mea hānau hānau.